ATE475663T1 - Lamellarinanaloga mit antitumorwirkung - Google Patents

Lamellarinanaloga mit antitumorwirkung

Info

Publication number
ATE475663T1
ATE475663T1 AT03784300T AT03784300T ATE475663T1 AT E475663 T1 ATE475663 T1 AT E475663T1 AT 03784300 T AT03784300 T AT 03784300T AT 03784300 T AT03784300 T AT 03784300T AT E475663 T1 ATE475663 T1 AT E475663T1
Authority
AT
Austria
Prior art keywords
lamellarine
analogue
antitumor effect
stereoisomer
prodrug
Prior art date
Application number
AT03784300T
Other languages
English (en)
Inventor
Christian Bailly
Solloso Andres Francesch
Urbano Maria Cristina Mateo
Guerrero Jose Antonio Jimenez
Del Castillo Alfredo Pastor
Marchante Carmen Cuevas
Original Assignee
Pharma Mar Sau
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sau filed Critical Pharma Mar Sau
Application granted granted Critical
Publication of ATE475663T1 publication Critical patent/ATE475663T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
AT03784300T 2002-08-13 2003-08-13 Lamellarinanaloga mit antitumorwirkung ATE475663T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0218816.7A GB0218816D0 (en) 2002-08-13 2002-08-13 Antitumoral analogs of lamellarins
PCT/GB2003/003541 WO2004014917A2 (en) 2002-08-13 2003-08-13 Antitumoral analogs of lamellarins

Publications (1)

Publication Number Publication Date
ATE475663T1 true ATE475663T1 (de) 2010-08-15

Family

ID=9942234

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03784300T ATE475663T1 (de) 2002-08-13 2003-08-13 Lamellarinanaloga mit antitumorwirkung

Country Status (17)

Country Link
US (1) US7396837B2 (de)
EP (2) EP1551844B1 (de)
JP (1) JP2005536529A (de)
KR (1) KR20050053613A (de)
CN (2) CN101941977A (de)
AT (1) ATE475663T1 (de)
AU (1) AU2003252997B2 (de)
CA (1) CA2493725A1 (de)
DE (1) DE60333578D1 (de)
GB (1) GB0218816D0 (de)
HK (1) HK1078580A1 (de)
IL (1) IL166513A0 (de)
MX (1) MXPA05001731A (de)
NO (1) NO20051282L (de)
NZ (1) NZ537935A (de)
RU (1) RU2328500C2 (de)
WO (1) WO2004014917A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071587B2 (en) 2009-05-27 2011-12-06 N. V. Organon (Dihydro)imidazoiso[5,1-A]quinolines
US8431564B2 (en) 2009-07-29 2013-04-30 Merck Sharp & Dohme B.V. Ring-annulated dihydropyrrolo[2,1-α]isoquinolines
TW201116531A (en) * 2009-07-29 2011-05-16 Organon Nv Ring-annulated dihydropyrrolo[2,1-a]isoquinolines
WO2011035417A1 (en) * 2009-09-25 2011-03-31 Aegera Therapeutics Inc. Hsp-90 binding compounds, compositions thereof, and their use fn the treatment of autoimmune and inflammatory diseases
JP5888702B2 (ja) * 2011-01-17 2016-03-22 国立大学法人 長崎大学 抗癌活性化合物
WO2012126084A1 (en) * 2011-03-24 2012-09-27 Pharmascience Inc. Hsp-90 binding compounds, compositions thereof, and their use iν the treatment and prevention of fungal infections
KR101721029B1 (ko) * 2014-10-16 2017-03-29 연세대학교 산학협력단 인돌리지노[3,2-c]퀴놀린 유도체, 이의 약제학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 낭포성 섬유증 예방 또는 치료용 약학조성물
TWI674265B (zh) * 2017-03-27 2019-10-11 東海大學 片螺素及其衍生物之製造方法
US11286261B2 (en) 2017-03-29 2022-03-29 Nagasaki University Fourth-generation EGFR tyrosine kinase inhibitor
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
CN112300232B (zh) * 2020-11-03 2021-11-09 浙江大学 Lamellarin D糖基化衍生物及其制备和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5852033A (en) * 1995-06-29 1998-12-22 Pharma Mar, S.A. Methods of treatment using lamellarin-class alkaloids
AUPO656597A0 (en) * 1997-05-02 1997-05-29 Australian National University, The Preparation of therapeutic compounds
AUPP433398A0 (en) * 1998-06-25 1998-07-16 Australian National University, The Compounds and processes

Also Published As

Publication number Publication date
RU2328500C2 (ru) 2008-07-10
CA2493725A1 (en) 2004-02-19
AU2003252997A1 (en) 2004-02-25
NO20051282L (no) 2005-05-11
WO2004014917A2 (en) 2004-02-19
EP1551844A2 (de) 2005-07-13
IL166513A0 (en) 2006-01-15
KR20050053613A (ko) 2005-06-08
NZ537935A (en) 2007-02-23
MXPA05001731A (es) 2005-08-16
CN1688585A (zh) 2005-10-26
CN101941977A (zh) 2011-01-12
DE60333578D1 (de) 2010-09-09
HK1078580A1 (en) 2006-03-17
US7396837B2 (en) 2008-07-08
AU2003252997B2 (en) 2009-08-06
WO2004014917A3 (en) 2004-05-13
RU2005106863A (ru) 2005-11-10
JP2005536529A (ja) 2005-12-02
EP2138496A1 (de) 2009-12-30
GB0218816D0 (en) 2002-09-18
US20060173030A1 (en) 2006-08-03
EP1551844B1 (de) 2010-07-28

Similar Documents

Publication Publication Date Title
NO20051282L (no) Antitumorale analoger av lamellariner.
FR18C1024I1 (fr) Derives d'heterocyclocarboxamide
RS51444B (sr) JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
TR200100432T2 (tr) Hepatit C inhibitörü tri-peptidler
WO2006005609A3 (de) Substituierte oxindol-derivate und diese enthaltende arzneimittel
PE20040636A1 (es) Ester de 2'-c-metil-3'-o-l-valina de ribofuranosilcitidina
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
NO20064077L (no) Kemokinreseptorantagonister
DE60236102D1 (en) 1h-indolderivate als hochselektive cyclooxygenase-2-inhibitoren
MY134129A (en) Polymorphs of an epothilone analog
ECSP044992A (es) Inhibidores de la alquín-aril fosfodiesterasa-4
EA200700997A1 (ru) 2,5- и 2,6-дизамещенные аналоги бензазола, полезные в качестве ингибиторов протеинкиназ
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
RS52315B (en) DIARYLMETHYL PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE
DK1643984T3 (da) Anvendelse af parthenolidderivater som antileukæmiske og cytotoksske midler
AU2001286768A1 (en) Novel macrocycles and uses thereof
KR950701615A (ko) 혈소판 응집 저해작용을 갖는 신규한 화합물(novel compound with plate-let aggregation inhibitor activity)
ATE208774T1 (de) Arylsulfonylimidazolon-derivate als antitumormittel
PT2112154E (pt) Ésteres na posição 20 de camptotecinas
EA200300272A1 (ru) Новые производные хиназолина, способ их получения и фармацевтические композиции, содержащие их
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents
HRP20080179T3 (en) Novel imidazopyridine compound ii with therapeutic effect
UY27628A1 (es) "2'-halo -3',5'-dialcoxi-fen-1'il-2-imidazolidinas y su uso como un fármaco"
IS8034A (is) Imídasó[4,5-B]kínólínafleiður og notkun þeirra sem NO-myndunarhemla
MXPA04002640A (es) Esteres de analogos de 3-desoxi-vitamina d3.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties